Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Cmg Pharmaceutical (058820 KS)
Watchlist
16
Analysis
Health Care
•
South Korea
CMG Pharmaceutical Co., Ltd. develops and markets general pharmaceuticals and healthcare functional pharmaceuticals, and manufactures apparatus used in medical treatments and surgeries.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Cross Asset Strategy
•
07 Oct 2022 23:26
KOSDAQ 150 Rebalance in December Highlighted by Locals
This article discusses the potential inclusions and exclusions of KOSDAQ 150 rebalance in December 2022 (especially those that are highlighted by...
Douglas Kim
Follow
515 Views
Share
bearish
•
Cross Asset Strategy
•
13 May 2022 07:27
Alpha Generating Trading Strategy of KOSDAQ150 Deletions & Additions in June 2022
An alpha generating trading strategy would be to focus on companies with higher probability of getting deleted in the next round of KOSDAQ...
Douglas Kim
Follow
500 Views
Share
bearish
•
Quantitative Analysis
•
23 Apr 2025 07:05
KRX Short Interest Weekly (Apr 18th): Hanmi Semi, SK Hynix, Samsung Electro-Mech, Sk Innovation
We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanmi Semi, SK Hynix, Samsungelecmech, Sk...
Ke Yan, CFA, FRM
Follow
855 Views
Share
bearish
•
Devsisters
•
17 Nov 2022 04:55
KOSDAQ150 Index Rebalance: 11 Changes with a Couple of Surprises
There are 11 changes at the Dec rebal: mostly in line with forecasts. SillaJen is a surprise add; Devsisters is a surprise delete. Short interest...
Brian Freitas
Follow
662 Views
Share
bullish
•
Lotte Confectionery
•
16 Nov 2022 20:52
KOSPI 200 & KOSDAQ 150 Rebalance Changes + KOSPI 200 & KOSDAQ 150 Exclusion Candidates in 2023
Korea Exchange announced the KOSPI 200, KOSDAQ 150, and KRX 300 rebalance changes today. Lotte Confectionery will be added and Samyang Holdings...
Douglas Kim
Follow
988 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x